Bio-Rad Laboratories, Inc. Class B
As of Oct 22, 2026, Bio-Rad Laboratories is in Stage 2, the uptrend phase, now in week 13 (since Jul 23, 2026). It closed at $364.15, at its 52-week high and above its 200-day average, which is rising.
Bio-Rad Laboratories, Inc. develops, manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, Latin America, and internationally. More about the company
Pro read
ProOur read
Setup score
Momentum
Edge
Setup-score rank among Stage 2 peers: #1 of 35 in Medical Devices · #1 of 272 in Health Care
Is BIO-B early, or has it already run? Pro answers that for every US stock we cover, after every close.
Renews monthly until you cancel. Cancel any time in Plan & billing.
BIO-B among Medical Devices30th of 141 by relative strength
All 141 →| # | Stock | Stage | RS | 1M |
|---|---|---|---|---|
| 1 | TXG | Stage 2 · wk 48 | 99 | −7.8% |
| 2 | RCEL | Stage 2 · wk 13 | 98 | +40.8% |
| 3 | BFLY | Stage 2 · wk 26 | 98 | −26.0% |
| 4 | HAE | Stage 2 · wk 17 | 96 | +8.7% |
| 5 | GKOS | Stage 2 · wk 25 | 96 | +15.1% |
| 6 | AXGN | Stage 3 · wk 2 | 95 | −15.3% |
| 7 | NEOG | Stage 2 · wk 14 | 95 | −11.7% |
| 8 | BVS | Stage 2 · wk 15 | 95 | +10.5% |
| …30 | BIO-B | Stage 2 · wk 13 | 75 | −0.3% |
Bio-Rad Laboratories: quick answers
What stage is Bio-Rad Laboratories in?
As of Oct 22, 2026, Bio-Rad Laboratories (BIO-B) is in Stage 2, the uptrend phase. It entered Stage 2 on Jul 23, 2026 and is in week 13. What the four stages mean
Is Bio-Rad Laboratories in an uptrend?
Yes. Bio-Rad Laboratories is in a Stage 2 uptrend. It trades 17.9% above its 200-day average, which is rising.
How far is Bio-Rad Laboratories from its 52-week high?
Bio-Rad Laboratories closed at $364.15 on Oct 22, 2026, at its 52-week high. Its 52-week low is $255.54.
How has Bio-Rad Laboratories performed over the past year?
As of Oct 22, 2026, Bio-Rad Laboratories is up 27.8% over the past year and up 17.2% so far in 2026.
Which sector and industry is Bio-Rad Laboratories in?
Bio-Rad Laboratories is in the Medical Devices industry, part of the Health Care sector.
About this companyHealth Care· Medical Devices
Bio-Rad Laboratories, Inc. develops, manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, Latin America, and internationally. It operates through two segments, Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets instruments, systems, reagents, and consumables to separate, purify, characterize, and quantify biological materials, including cells, proteins, and nucleic acids used in research and biopharmaceutical laboratory environments, as well as for biopharmaceutical manufacturing, quality control process, food safety, and science education applications. This segment serves universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology companies, food producers, and testing laboratories. Its Clinical Diagnostics segment designs, manufactures, markets, and supports diagnostic test systems, informatics systems, test kits, and specialized quality controls for clinical, hospital, diagnostic reference, and transfusion and physician office laboratories, as well as software. The company offers its products through its direct commercial organization, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.
Visit company website →All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.